Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
6761
-
6762
-
6763
-
6764
A comprehensive analysis of molecular characteristics of hot and cold tumor of gastric cancer
Published 2025-02-01Get full text
Article -
6765
-
6766
Construction of a prognostic prediction model for colorectal cancer based on 5-year clinical follow-up data
Published 2025-01-01Get full text
Article -
6767
-
6768
Adenoid cystic carcinoma of the breast, from diagnosis to management: a case report
Published 2025-01-01Get full text
Article -
6769
The Frequency of <i>DPYD</i> c.557A>G in the Dominican Population and Its Association with African Ancestry
Published 2024-12-01“…The implementation of pharmacogenetics in oncology, specifically <i>DPYD</i>, in populations of Afro-Latin American ancestry should include c.557A>G, to be able to carry out the safe and effective treatment of patients treated with fluoropyrimidines.…”
Get full text
Article -
6770
-
6771
-
6772
-
6773
Secondary neoplasms in survivors of pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center, retrospective study
Published 2025-01-01“…The aim of this study was to evaluate the incidence of, risk factors for, and outcomes of secondary neoplasms in long-term survivors of ALL and LBL at a tertiary pediatric oncology center in Mie prefecture, Japan.ProcedureWe retrospectively reviewed 188 patients with ALL and LBL who were treated with an ALL-based therapeutic regimen at Mie University Hospital from January 1, 1977 to December 31, 2022 and followed up.ResultsTen patients developed secondary neoplasms, with 10-year and 20-year cumulative incidences of 2.9% [standard error (SE) = 1.5%] and 5.5% (SE = 2.3%), respectively. …”
Get full text
Article -
6774
mTORC1-Activated Monocytes Increase Tregs and Inhibit the Immune Response to Bacterial Infections
Published 2016-01-01Get full text
Article -
6775
-
6776
-
6777
The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer
Published 2024-07-01“…Methods Patients in the veterans affairs national precision oncology program from 1/2019–12/2021 who received first-line ICI for advanced NSCLC were followed until death or study end 6/2022. …”
Get full text
Article -
6778
-
6779
-
6780